Stockscreener 앱 받기
14.99
0.00%
0.010
Xencor Inc 주식(XNCR)의 최신 뉴스
Enterprise value to revenue forward of Xencor, Inc. – NASDAQ:XNCR - TradingView
Price to earnings forward of Xencor, Inc. – NASDAQ:XNCR - TradingView
Price to sales forward of Xencor, Inc. – TRADEGATE:XE9 - TradingView
Liquidity Mapping Around (XNCR) Price Events - Stock Traders Daily
XE9 Forecast — Price Target — Prediction for 2027 - TradingView
Xencor, Inc. Actuals & Estimates (FWB:XE9) - TradingView
XNCR Forecast — Price Target — Prediction for 2027 - TradingView
Xencor, Inc. Actuals & Estimates (NASDAQ:XNCR) - TradingView
Price to book forward of Xencor, Inc. – NASDAQ:XNCR - TradingView
Xencor Inc (XNCR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Xencor director Ellen Feigal sells $89,369 in company stock By Investing.com - Investing.com South Africa
Insider Sell Alert: Ellen Feigal Sells Shares of Xencor Inc (XNC - GuruFocus
Form 4 Xencor Inc For: 22 June By Investing.com - Investing.com Nigeria
Xencor director Ellen Feigal sells $89,369 in company stock - Investing.com
Xencor (XNCR) director’s 10b5-1 sale covers 6,843 common shares - Stock Titan
XNCR Q1 2026 Earnings: Deep Loss Miss Weighs on SentimentProfit Warning Alert - dars.gov.et
Xencor, Inc. Files 8-K: Company Details, Stock Info, and Executive Plan Updates for 2026 - Minichart
Xencor Shareholders Approve Directors, Incentive Plan Amendments - TipRanks
Why (XNCR) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Xencor (NASDAQ: XNCR) investors back 4M-share equity plan boost and all proposals - Stock Titan
Xencor Inc (XNCR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
[144] Xencor Inc SEC Filing - Stock Titan
Insider Sell Alert: Richard Ranieri Sells Shares of Xencor Inc (XNCR) - GuruFocus
Xencor Inc (XNCR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Xencor Inc (XNCR) Institutional Confidence - TradingKey
Xencor Inc (XNCR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Xencor Inc (XNCR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Xencor Inc (XNCR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Xencor Inc (XNCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Xencor Inc (XNCR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Director at Xencor (XNCR) sells 7,527 shares under 10b5-1 plan - Stock Titan
Xencor (XNCR) director sells 5,474 shares under Rule 10b5-1 plan - Stock Titan
Xencor (XNCR) director Ranieri sells 5,474 shares under 10b5-1 plan - Stock Titan
Planned share sale by Xencor (XNCR) director under Rule 10b5-1 plan - Stock Titan
Barclays Maintains Xencor(XNCR.US) With Buy Rating, Maintains Target Price $27 - Moomoo
Xencor (XNCR) Stock Draws Fresh Price Target Split As Pipeline Progress Meets Caution - Yahoo Finance
Xencor Inc Stock (US98401F1057): Analyst Views In Focus After Recent Collaboration Momentum - AD HOC NEWS
Understanding Momentum Shifts in (XNCR) - Stock Traders Daily
Xencor (XNCR) Slides 2% as Biotech Sentiment Weakens — Support TestedTRIN Signal - newsline.com
Incyte lymphoma therapy lifts cancer-free survival by 25% in late-stage trial - MSN
Xencor Inc stock (US98401F1057): shares react to Monjuvi first-line lymphoma update and recent Q1 20 - AD HOC NEWS
XNCR Technical Analysis & Stock Price Forecast - Intellectia AI
XNCR Q1 2026 Earnings: Deep Loss Miss as Pipeline Biotech Faces Market SkepticismInterim Report - The Legal Advocate
XNCR Q1 2026 Earnings: Significant EPS Miss Amidst Clinical Development ProgressAnnual Report - newsline.com
XNCR Q1 2026 Earnings: Deeper-than-Expected Loss Highlights Persistent R&D InvestmentEarnings Revision Upgrade - newsline.com
Xencor Inc stock (US98401F1057): shares trade around recent lows as investors digest pipeline and va - AD HOC NEWS
XNCRXencor Inc Stock Price and Quote - Finviz
Avoiding Lag: Real-Time Signals in (XNCR) Movement - Stock Traders Daily
Xencor Inc. (XNCR) Holds Ground Near $11.31: Key Levels in FocusComposite Profile - Newser
0.40%
0.51%
자본화:
|
볼륨(24시간):